MENU
ATHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Athira Pharma (ATHA) Ownership - Who owns Athira Pharma?
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more
Profile
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.45M
P/E Ratio
N/A
Total Cash
36.67M
Projected Growth
N/A
Total Debt
1.12M
Revenue
N/A
Risk (Beta)
2.45
Dividend Yield
N/A
Total Cash/Share
0.94
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ATHA
Capitalization
14.4M
P/E Ratio
N/A
Risk (Beta)
2.45
Dividend Yield
N/A
Total Cash
36.7M
Total Cash/Share
0.94
Total Debt
1.12M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
37.3M
P/B Ratio
0.39
Cash Flow
N/A
Earnings
-2.06
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
7.26
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-77.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-90.12
Shares Held By Institutions
5.73M
Shares Outstanding - Current
39M
Total Liabilities
6.18M
Total Volume MTD
N/A
Value
1
Gain YTD
-35.401
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATHA showed earnings on May 09, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com